GAPDH and neoplasm: In addition, we found several cytoskeletal molecules, including tubulin [38], cofilin [39] and a glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) known to be involved in tumor progression, were dramatically decreased after a long-term treatment of the HuCCT1 tumor on mouse skin with the Src inhibitor dasatinib.